Clinical Trial Update: A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating BEY1107 in combination with capecitabine for metastatic colorectal cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BEY1107
• Capecitabine (capecitabine)

Snippet

Sponsor: BeyondBio Inc. | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: RECRUITING